India, April 30 -- AstraZeneca has confirmed in court documents that its COVID-19 vaccine, developed in collaboration with the University of Oxford, can cause a rare side effect called thrombosis with thrombocytopenia syndrome (TTS), according to a report released in a British newspaper.

The vaccine has been admitted amid a class-action lawsuit claiming numerous deaths and injuries, with victims and their families seeking up to 100 million in damages, UNI news agency reported quoting the British newspaper.

According to Telegraph UK, The lawsuit was Initiated by Jamie Scott, a father of two, who suffered a permanent brain injury after developing a blood clot and a bleed on the brain following his vaccination in April 2021.

The legal bat...